Adding strong support to the deleterious role of zinc-induced-PARP activation in the etiology of hypoglycemia, hypoglycemia-induced hippocampal neuronal death and spatial learning ability impairment were significantly spared by treatment with PARP inhibitors [5] and by zinc chelators [21]. This evidence concerns the gene PARP1 and Hypoglycemia.